InspireMD (NSPR) Cash from Financing Activities (2010 - 2025)

InspireMD's Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $52.9 million for Q3 2025.

• On a quarterly basis, Cash from Financing Activities rose 5584.56% year-over-year to $52.9 million in Q3 2025; TTM through Dec 2025 was $55.6 million, a 9192.47% increase from a year earlier, with the FY2025 full-year figure at $55.6 million, up 201.15% from the prior year.
• Cash from Financing Activities climbed to $52.9 million in Q3 2025 per NSPR's latest filing, from $2.1 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $52.9 million in Q3 2025 and bottomed at -$965000.0 in Q3 2024.
• The 4-year median for Cash from Financing Activities is $506000.0 (2025), against an average of $10.1 million.
• Across the five-year window, Cash from Financing Activities jumped 1168833.33% in 2021 and plunged 194.29% in 2022, its largest moves.
• Year by year, Cash from Financing Activities stood at -$35000.0 in 2021, then plunged by 194.29% to -$103000.0 in 2022, then surged by 1617.48% to $1.6 million in 2024, then surged by 3286.18% to $52.9 million in 2025.
• Per Business Quant, the three latest NSPR Cash from Financing Activities figures stand at $52.9 million (Q3 2025), $2.1 million (Q2 2025), and $506000.0 (Q1 2025).